News to note of today would definitely include the Astra Zeneca anti-hyperlipidemia drug Crestor, is supposed to be much better than everyone thought. Or that is what there new study sais. They are claiming the drug is significant in reducing the risk of severe cardiovascular events. A study called "Jupiter" proves the drug can now be recommend for more folks meaning more drug sales. How do we play this? It can be another hype creation publicity stunt created by the manufacture. If it does create hype and a rally in shares of AZN it would produce a shorting opportunity. In my experience most drug stock are quite manipulated to the downside with bad news it's not a frequent occurrence that one gets talked up and it remains up. In other words this could be a good play but get out before the FDA pulls it off the shelves because it causes liver and kidney damage.